Jerry D. Gardner
#122,093
Most Influential Person Now
Jerry D. Gardner's AcademicInfluence.com Rankings
Jerry D. Gardnermedical Degrees
Medical
#1881
World Rank
#2262
Historical Rank
Pharmacology
#182
World Rank
#221
Historical Rank

Download Badge
Medical
Jerry D. Gardner's Degrees
- PhD Pharmacology University of California, San Francisco
- Bachelors Chemistry University of California, Berkeley
Why Is Jerry D. Gardner Influential?
(Suggest an Edit or Addition)Jerry D. Gardner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists. (1981) (237)
- Intraoperative Ultrasonographic Localization of Islet Cell Tumors: A Prospective Comparison to Palpation (1988) (233)
- Interactions of COOH-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea pig pancreas. (1982) (216)
- Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells. (1980) (209)
- Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells. (1978) (207)
- Zollinger-Ellison syndrome: current concepts and management. (1983) (196)
- Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Structural requirements for effects of vasoactive intestinal peptide and secretin on cellular adenosine 3':5'-monophosphate. (1976) (193)
- Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Binding of radioiodinated peptide. (1976) (189)
- Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera. (1985) (187)
- Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study. (1989) (185)
- Probing peptide backbone function in bombesin. A reduced peptide bond analogue with potent and specific receptor antagonist activity. (1988) (183)
- Regulation of amylase release from dispersed pancreatic acinar cells. (1977) (173)
- Interaction of CCK with pancreatic acinar cells. (1989) (172)
- Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome. (1985) (166)
- Kinetics of amylase release by dispersed acini prepared from guinea pig pancreas. (1978) (161)
- A synthetic peptide that is a bombesin receptor antagonist (1984) (159)
- Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study. (1987) (155)
- Prospective Study of Gastrinoma Localization and Resection in Patients with Zollinger‐Ellison Syndrome (1986) (151)
- Cushing's syndrome in patients with the Zollinger-Ellison syndrome. (1986) (149)
- Actions of derivatives of cyclic nucleotides on dispersed acini from guinea pig pancreas. Discovery of a competitive antagonist of the action of cholecystokinin. (1979) (148)
- Aggressive Resection of Metastatic Disease in Selected Patients with Malignant Gastrinoma (1986) (145)
- Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study. (1989) (142)
- Action of cholecystokinin and cholinergic agents on calcium transport in isolated pancreatic acinar cells. (1975) (142)
- Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study. (1989) (141)
- Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. (1988) (140)
- Reflux esophagitis in patients with Zollinger-Ellison syndrome. (1990) (128)
- Regulation of pancreatic exocrine function in vitro: initial steps in the actions of secretagogues. (1979) (128)
- Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states. (1983) (125)
- Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors. (1989) (124)
- Detection of duodenal gastrinomas by operative endoscopic transillumination. A prospective study. (1990) (124)
- Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome. (1985) (123)
- Action of cholecystokinin, cholinergic agents, and A-23187 on accumulation of guanosine 3':5'-monophosphate in dispersed guinea pig pancreatic acinar cells. (1976) (122)
- Gastrinomas: localization by means of selective intraarterial injection of secretin. (1990) (118)
- Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome. (1983) (114)
- Prospective study of the ability of computed axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome. (1987) (113)
- Viral gastroenteritis induced by the Hawaii agent. Jejunal histopathology and serologic response. (1975) (109)
- Prospective study of chemotherapy in patients with metastatic gastrinoma. (1988) (108)
- Role of selective angiography in the management of patients with Zollinger-Ellison syndrome. (1987) (105)
- Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion. (1984) (101)
- The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells. (1990) (99)
- Localization of islet cell tumors by dynamic CT: comparison with plain CT, arteriography, sonography, and venous sampling. (1984) (99)
- Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study. (1988) (98)
- The Effects of Sodium and Potassium on Ouabain Binding by Human Erythrocytes (1972) (97)
- Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome. (1992) (96)
- Gastric emptying and secretion in Zollinger-Ellison syndrome. (1977) (92)
- Effects of vasoactive intestinal peptide, secretin, and related peptides on rat colonic transport and adenylate cyclase activity. (1977) (91)
- Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity. (1989) (89)
- Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists. (1983) (87)
- Pancreatic cholera: benefical effects of treatment with streptozotocin. (1975) (84)
- Selective venous sampling for gastrin to localize gastrinomas. A prospective assessment. (1986) (83)
- Insulin action in isolated rat thymocytes. I. Binding of 125 I-insulin and stimulation of -aminoisobutyric acid transport. (1972) (83)
- Receptor occupation, calcium mobilization, and amylase release in pancreatic acini: effect of CCK-JMV-180. (1989) (78)
- Measurement of meal-stimulated gastric acid secretion by in vivo gastric autotitration. (2002) (76)
- CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors. (1989) (76)
- Cyclic AMP in pancreatic acinar cells: effects of gastrointestinal hormones. (1976) (73)
- Receptors for vasoactive intestinal peptide and secretin on rat pancreatic acini. (1984) (73)
- Importance of sulfation of gastrin or cholecystokinin (CCK) on affinity for gastrin and CCK receptors (1989) (68)
- H2-Histamine receptor blocking agents in the Zollinger-Ellison syndrome. Experience in seven cases and implications for long-term therapy. (1977) (68)
- Effect of β-Adrenergic Catecholamines on Sodium Transport in Turkey Erythrocytes (1973) (68)
- Alterations of in vitro fluid and electrolyte absorption by gastrointestinal hormones. (1967) (67)
- Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors (1989) (66)
- Interaction of Bombesin and Related Peptides with Receptors on Pancreatic Acinar Cells (1988) (66)
- Pepsinogen secretion from dispersed chief cells from guinea pig stomach. (1984) (64)
- Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists. (1989) (64)
- Cholecystokinin (pancreozymin). 4. Synthesis and properties of a biologically active analogue of the C-terminal heptapeptide with epsilon-hydroxynorleucine sulfate replacing tyrosine sulfate. (1978) (62)
- [D-Phe12]bombesin analogues: a new class of bombesin receptor antagonists. (1987) (61)
- Characterization of gastrin receptors on guinea pig pancreatic acini. (1987) (61)
- Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states. (1984) (59)
- Effects of gastrointestinal hormones on adenylate cyclase activity in human jejunal mucosa. (1975) (58)
- Mechanism of [Tyr4]bombesin-induced desensitization in dispersed acini from guinea pig pancreas. (1982) (57)
- Interaction of physalaemin, substance P, and eledoisin with specific membrane receptors on pancreatic acinar cells. (1979) (57)
- Cholecystokinin-induced formation of inositol phosphates in pancreatic acini. (1990) (57)
- Multiple affinity states of different cholecystokinin receptors. (1994) (56)
- Effects of interleukin-6 on fetal hematopoietic progenitors. (1990) (56)
- Cholecystokinin receptor antagonists. (1984) (55)
- Altered membrane sodium transport in Bartter's syndrome. (1972) (54)
- Structural features of various proglumide-related cholecystokinin receptor antagonists. (1986) (52)
- Interaction of secretin5-27 and its analogues with hormone receptors on pancreatic acini. (1979) (51)
- [Cholecystokinin-pancreozymin synthesis. Synthesis of [28-threonine,31-norleucine]- and [28-threonine,31-leucine]cholecystokinin-pancreozymin-(25-33)-nonapeptide]. (1981) (50)
- Characterization of receptors for calcitonin gene-related peptide on gastric smooth muscle cells. (1988) (50)
- Pancreatic receptors for cholecystokinin: evidence for three receptor classes. (1990) (50)
- Interaction of substance P antagonists with substance P receptors on dispersed pancreatic acini. (1984) (49)
- Actions of Gila monster venom on dispersed acini from guinea pig pancreas. (1982) (49)
- Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: a comparative study. (1988) (48)
- Effects of alcohols on the actions of VIP and secretin on acinar cells from guinea pig pancreas. (1979) (48)
- Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinase C (PKC) in pancreatic acini. (1994) (48)
- Direct demonstration of three different states of the pancreatic cholecystokinin receptor. (1994) (48)
- Cellular cyclic AMP in dispersed mucosal cells from guinea pig stomach. (1978) (48)
- Receptors for vasoactive intestinal peptide and secretin on small intestinal epithelial cells. (1980) (48)
- Effects of digoxin-specific antibodies on accumulation and binding of digoxin by human erythrocytes. (1973) (47)
- Cellular distribution of isoforms of protein kinase C (PKC) in pancreatic acini. (1995) (47)
- Famotidine in the therapy of gastric hypersecretory states. (1986) (47)
- Cholecystokinin (pancreozymin). 3. Synthesis and properties of an analogue of the C-terminal heptapeptide with serine sulfate replacing tyrosine sulfate. (1977) (47)
- Inhibition of parietal cell function by human gammaglobulin containing gastric parietal cell antibodies. (1980) (47)
- Cholecystokinin-induced contraction of dispersed smooth muscle cells. (1982) (46)
- Abnormal membrane sodium transport in Liddle's syndrome. (1971) (45)
- Structural requirements for action of cholecystokinin on enzyme secretion from pancreatic acini. (1982) (44)
- Actions of a newly isolated intestinal peptide PHI on pancreatic acini. (1981) (44)
- Proglumide analogues: potent cholecystokinin receptor antagonists. (1985) (43)
- Intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery. (1990) (43)
- Receptors and cell activation associated with pancreatic enzyme secretion. (1986) (42)
- Postreceptor modulation of action of VIP and secretin on pancreatic enzyme secretion by secretagogues that mobilize cellular calcium. (1982) (42)
- Regulation of pancreatic exocrine secretion in vitro: the action of secretagogues. (1981) (41)
- Parenteral antisecretory drug therapy in patients with Zollinger-Ellison syndrome. (1989) (41)
- Receptor for secretagogues on pancreatic acinar cells. (1980) (41)
- Famotidine: effective treatment of Zollinger-Ellison syndrome. (1987) (41)
- Cholecystokinin-induced desensitization of enzyme secretion in dispersed acini from guinea pig pancreas. (1980) (40)
- Receptors for secretagogues on pancreatic acinar cells. (1984) (39)
- Transport of dibasic amino acids by human erythrocytes. (1972) (39)
- Mechanism of action of calcitonin gene-related peptide in stimulating pancreatic enzyme secretion. (1986) (39)
- Use of 125I-secretin to identify and characterize high-affinity secretin receptors on pancreatic acini. (1983) (39)
- Receptors for gastrointestinal hormones. (1979) (37)
- Gastric emptying and secretion in the rhesus monkey. (1977) (37)
- Multiple hormone elevations in Zollinger-Ellison syndrome: Prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndrome (1990) (37)
- Sequence of events mediating the effect of cholera toxin on rat thymocytes. (1974) (36)
- Effect of substitutions in position 12 of bombesin on antagonist activity (1989) (36)
- Cyclic nucleotide-dependent protein kinase activity in acinar cells from guinea pig pancreas. (1978) (36)
- Integrated acidity and rabeprazole pharmacology (2002) (36)
- Potentiation of pepsinogen secretion from dispersed glands from rat stomach. (1983) (36)
- Ovarian Carcinoma as a Cause of Zollinger-Ellison Syndrome Natural History, Secretory Products, and Response to Provocative Tests (1989) (35)
- Thapsigargin defines the roles of cellular calcium in secretagogue-stimulated enzyme secretion from pancreatic acini. (1992) (35)
- Identification and characterization of receptors for secretagogues on pancreatic acinar cells. (1981) (35)
- COOH-terminal fragments of cholecystokinin. A new class of cholecystokinin receptor antagonists. (1983) (34)
- Beneficial effect of oral lithium carbonate in the treatment of pancreatic cholera syndrome. (1980) (34)
- Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome. (1991) (34)
- Properties of receptors for gastrin and CCK on gastric smooth muscle cells. (1989) (34)
- A prospective study of perioperative and postoperative control of acid hypersecretion in patients with Zollinger-Ellison syndrome undergoing gastrinoma resection. (1988) (34)
- Interaction of peptides related to secretin with hormone receptors on pancreatic acinar cells. (1976) (33)
- Effects of beta-adrenergic catecholamines on potassium transport in turkey erythrocytes. (1975) (33)
- Actions of peptides isolated from amphibian skin on pancreatic acinar cells. (1978) (32)
- Effects of cholecystokinin on adenylate cyclase activity in dispersed pancreatic acinar cells. (1977) (32)
- Characterization of cholinergic receptors mediating pepsinogen secretion from chief cells. (1989) (31)
- Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. (1989) (31)
- Effect of extracellular manganese on amylase release from dispersed pancreatic acini. (1979) (31)
- Reversal of the pharmacological and toxic effects of cardiac glycosides by specific antibodies. (1973) (31)
- Solid-phase synthesis of porcine vasoactive intestinal peptide. (2009) (31)
- Jejunal adenylate cyclase activity in human subjects during viral gastroenteritis. (1976) (31)
- Interaction of synthetic 10-tyrosyl analogues of secretin with hormone receptors on pancreatic acinar cells. (1977) (31)
- Functionally distinct receptors for cholecystokinin and gastrin on dispersed chief cells from guinea pig stomach. (1988) (30)
- Receptors for vasoactive intestinal peptide and secretin on guinea pig pancreatic acini (1987) (29)
- Beta-adrenergic receptors, cyclic AMP, and ion transport in the avian erythrocyte. (1975) (29)
- Down-regulation and recycling of high affinity cholecystokinin receptors on pancreatic acinar cells. (1991) (28)
- Evidence against cyclic GMP as a mediator of the actions of secretagogues on amylase release from guinea-pig pancreas. (1980) (28)
- Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini. (1989) (28)
- Action of natural glucagon on pancreatic acini: due to contamination by previously undescribed secretagogues. (1983) (27)
- Characterization of ability of various substance P antagonists to inhibit action of bombesin. (1988) (27)
- Action of cholera toxin on dispersed acini from guinea pig pancreas. (1979) (27)
- Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33. (2009) (27)
- Direct determination of ligand interactions with beta-adrenergic receptors on intact turkey erythrocytes: correlation of binding with biological activity. (1976) (27)
- Secretagogue-induced membrane alterations in dispersed acini from rat pancreas. (1984) (27)
- Effects of extracellular cations and ouabain on catecholamine-stimulated sodium and potassium fluxes in turkey erythrocytes. (1975) (26)
- Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini. (1994) (26)
- Integrated acidity and the pathophysiology of gastroesophageal reflux disease. (2001) (26)
- Action of cholecystokinin and cholinergic agents on membrane-bound calcium in dispersed pancreatic acinar cells. (1976) (26)
- Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome (1993) (26)
- Potential mechanisms of interaction among secretagogues (1978) (25)
- Calcium-activated, phospholipid-dependent protein kinase in pancreatic acinar cells. (1985) (25)
- Actions of vasoactive intestinal peptide and secretin on chief cells prepared from guinea pig stomach. (1986) (25)
- Activities of calcitonin gene-related peptide (CGRP) and related peptides at the CGRP receptor (1990) (25)
- Diagnosis and management of Zollinger-Ellison syndrome. (1989) (24)
- Hyperhistaminemia and hyperchlorhydria in basophilic granulocytic leukemia. (1976) (24)
- Pepsinogen secretion from dispersed glands from rabbit stomach. (1983) (24)
- Bombesin-induced desensitization of enzyme secretion in dispersed acini from guinea pig pancreas. (1980) (24)
- Action of histamine on cyclic AMP in guinea pig gastric cells: inhibition by H1- and H2-receptor antagonists. (1979) (23)
- Cyclic nucleotide antagonists of cholecystokinin: structural requirements for interaction with the cholecystokinin receptor. (1982) (23)
- The columnar epithelial cell of the small intestine: digestion and transport. 3. (1970) (23)
- Reduced peptide bond pseudopeptide analogues of substance P. A new class of substance P receptor antagonists with enhanced specificity. (1989) (23)
- Diagnosis and management of the Zollinger-Ellison syndrome. (1989) (22)
- The importance of the amino acid in position 27 of cholecystokinin in determining its biological activity on pancreatic acini. (1980) (22)
- Receptor function and ion transport in turkey erythrocytes. (1976) (22)
- Integrated acidity and the pathophysiology of gastroesophageal reflux disease (2001) (22)
- Mechanism of action of ATP on intestinal epithelial cells. Cyclic AMP-mediated stimulation of active ion transport. (1982) (21)
- Multiple hormone elevations in Zollinger-Ellison syndrome. Prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndrome. (1990) (21)
- The columnar epithelial cell of the small intestine: digestion and transport. (First of three parts). (1970) (21)
- Stereologic investigations of human gastric mucosa. II. Oxyntic mucosa from patients with Zollinger-Ellison syndrome. (1992) (21)
- Gastrointestinal peptides: the basis of action at the cellular level. (1983) (21)
- Receptor antagonists for gastrointestinal peptides. (1993) (20)
- The importance of the amino acid in position 32 of cholecystokinin in determining its interaction with cholecystokinin receptors on pancreatic acini. (1981) (19)
- Structure-function studies of N-acyl derivatives of tryptophan that function as specific cholecystokinin receptor antagonists. (1983) (19)
- Zollinger-Ellison syndrome. Recent advances in the management of the gastrinoma. (1990) (19)
- Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome. (1989) (19)
- Carbachol Does Not Down‐Regulate Substance P Receptors in Pancreatic Acini (1992) (19)
- Persistent constipation and abdominal adverse events with newer treatments for constipation (2016) (18)
- Potassium transport in dispersed mucosal cells from guinea pig stomach. (1978) (18)
- Calcium transport in dispersed acinar cells from rat pancreas. (1977) (18)
- An analogue of substance P with broad receptor antagonist activity. (1988) (18)
- Characterization of the bombesin receptor on mouse pancreatic acini by chemical cross-linking (1990) (18)
- Synergy between low‐dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal‐induced heartburn (2001) (18)
- Actions of peptides isolated from amphibian skin on amylase release from dispersed pancreatic acini. (1979) (17)
- Cimetidine pharmacokinetics in patients with Zollinger-Ellison syndrome. (1987) (17)
- Bombesin-induced residual stimulation of amylase release from mouse pancreatic acini. (1985) (17)
- Peptic ulcer perforation as the presentation of Zollinger-Ellison syndrome (2005) (17)
- 8 – Cholecystokinin Receptor Antagonists: Ability to Distinguish Various Classes of Cholecystokinin Receptors (1990) (17)
- Cholecystokinin-induced persistent stimulation of enzyme secretion from pancreatic acini. (1981) (17)
- Post-reflux swallow-induced peristaltic wave (PSPW): physiology, triggering factors and role in reflux clearance in healthy subjects (2020) (17)
- Cyclic GMP does not inhibit protein kinase C-mediated enzyme secretion in rat pancreatic acini. (1989) (16)
- Binding of 125I-CCK-8 and 125I-gastrin-I to dispersed chief cells from guinea-pig stomach. (1990) (16)
- Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking. (1987) (16)
- Synthesis and some pharmacological properties of the 23-peptide 15-lysine-secretin-(5--27). Special role of the residue in position 15 in biological activity of the vasoactive intestinal polypeptide. (1978) (16)
- Control of Nocturnal Gastric Acidity: A Role for Low Dose Bedtime Ranitidine to Supplement Daily Omeprazole (2002) (16)
- Cholecystokinin-induced restricted stimulation of pancreatic enzyme secretion. (1982) (16)
- Carbobenzoxy amino acids: structural requirements for cholecystokinin receptor antagonist activity. (1985) (16)
- In vitro Inhibition of Intestinal Fluid and Electrolyte Transfer by a Non-Beta Islet Cell Tumor (1966) (16)
- Effect of cholecystokinin variant (CCK39) on dispersed acinar cells from guinea pig pancreas. (1977) (16)
- Low mannitol clearance into cholera stool as evidence against filtration as the source of stool fluid. (1972) (15)
- Effects of ouabain on catecholamine-stimulated sodium transport in turkey erythrocytes. (1974) (15)
- Ouabain binding and cation transport in human erythrocytes. (1973) (15)
- Impaired renal tubular secretion of potassium, elevated sweat sodium chloride concentration and plasma inhibition of erythrocyte sodium outflux as complications of systemic lupus erythematosus. (1972) (15)
- Biochemical regulation of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini. (1994) (15)
- Effect of extracellular calcium on amylase release from dispersed pancreatic acini. (1979) (15)
- Characterization of cholecystokinin receptors on the sphincter of Oddi. (1990) (15)
- Dispersed pancreatic acinar cells and pancreatic acini. (1990) (15)
- Cholecystokinin (pancreozymin). 5. Hormonally active desamino derivative of Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2. (1980) (14)
- Modulation of cholecystokinin activity by albumin. (1995) (14)
- Frequency analyses of gastric pH in control and gastro‐oesophageal reflux disease subjects treated with a proton‐pump inhibitor (2004) (14)
- Successful Therapy of Pancreatic Cholera with the Long-Acting Somatostatin Analogue SMS 201-995: Relation between Plasma Concentrations of Drug and Clinical and Biochemical Responses (1986) (14)
- Occupation of low-affinity cholecystokinin (CCK) receptors by CCK activates signal transduction and stimulates amylase secretion in pancreatic acinar cells. (1993) (14)
- Kinetics of binding of cholecystokinin to pancreatic acini. (1988) (14)
- Gastrin and colon cancer: a unifying hypothesis. (1996) (13)
- Amino acid transport in isolated rat thymocytes. Effects of divalent cations and ethanol. (1976) (12)
- Abnormal Erythrocyte Sodium Transport in Cystic Fibrosis of the Pancreas (1971) (12)
- Stimulation of sodium transport in turkey erythrocytes by cyclic 3',5'-AMP. (1974) (12)
- Effects of inhibitors of cyclic nucleotide phosphodiesterase on actions of cholecystokinin, bombesin, and carbachol on pancreatic acini. (1983) (12)
- Synthesis and some pharmacological properties of Z-Tyr(SO3H)-Met-Gly-Trp-Met-Asp(Phe-NH2)-OH, a 32-beta-aspartyl analogue of cholecystokinin (pancreozymin) 27-33. (1982) (12)
- Refractoriness of cation transport in turkey erythrocytes to stimulation by cyclic adenosine 3':5'-monophosphate. (1975) (11)
- Mycobacterium fortuitum infection: evidence of bactericidal defect due to hyperactive antigen-specific suppressor cells. Correction in vitro and in vivo by cholinergic agonist and indomethacin. (1982) (11)
- Action of theophylline on secretagogue-stimulated amylase release from dispersed pancreatic acini. (1980) (11)
- Ovarian carcinoma as a cause of Zollinger-Ellison syndrome. Natural history, secretory products, and response to provocative tests. (1989) (11)
- Cholecystokinin (CCK)-induced desensitization of pancreatic enzyme secretion is mediated by low affinity CCK receptors (1989) (11)
- Dental identification of remains from the 23 October 1983 bombing of the U.S. Marine Headquarters, Beirut, Lebanon. (1985) (11)
- PRODUCTION AND PROPERTIES OF DIGOXIN‐SPECIFIC ANTIBODIES * (1974) (11)
- Regulation of bombesin receptors on pancreatic acini by cholecystokinin. (1989) (11)
- Gastrointestinal peptides and cancer (1993) (10)
- In vitro growth of epithelial cells from mucosa derived from different regions of the gastrointestinal tract (1987) (10)
- Integrated gastric acidity can predict the prevention of naproxen-induced gastroduodenal pathology in normal subjects (2003) (10)
- Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini. (1984) (10)
- Cholecystokinin Receptor Antagonists In Vitro (1991) (10)
- Increased jejunal IgA synthesisin vitro during acute infectious nonbacterial gastroenteritis (1974) (10)
- Interaction of tryptophan-modified analogues of cholecystokinin-octapeptide with cholecystokinin receptors on pancreatic acini. (1981) (9)
- Actions of natural gastric inhibitory peptide on pancreatic acinar cells: due to contamination with cholecystokinin. (1982) (9)
- Cell membrane receptors for secretagogues on pancreatic acinar cells (1988) (9)
- Effect of A23187 on amylase release from dispersed acini prepared from guinea pig pancreas. (1980) (9)
- Reversal of cholecystokinin-induced persistent stimulation of pancreatic enzyme secretion by dibutyryl cyclic GMP. (1981) (9)
- Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase. (1986) (8)
- Sodium transport in human erythrocytes--absence of an effect of prostaglandin E1. (1971) (8)
- Discovery of a cholecystokinin analogue with partial agonist activity. (1984) (8)
- Action of VIP and secretin on adenylate cyclase activity in acinar cells from guinea pig pancreas. (1979) (8)
- Effects of calcium and chelating agents on the ability of various agonists to increase cyclic GMP in pancreatic acinar cells. (1978) (8)
- Carbachol desensitizes pancreatic enzyme secretion by downregulation of receptors. (1990) (8)
- Effects of inhibitors of cyclic nucleotide phosphodiesterase on the actions of vasoactive intestinal peptide and secretin on pancreatic acini. (1982) (8)
- Follow-up of a patient with somatostatinoma. (1986) (7)
- Role of sulfate ester in influencing biologic activity of cholecystokinin-related peptides. (1987) (7)
- Effects of saliva and plasma from cystic fibrosis patients on membrane transport. (1972) (7)
- Action of cholera toxin on dispersed acini from rat pancreas. Post-receptor modulation involving cyclic AMP and calcium. (1982) (7)
- Diagnosis and Management of the Zollinger‐Ellison Syndrome (1983) (7)
- Effect of inhibition of microsomal Ca(2+)-ATPase on cytoplasmic calcium and enzyme secretion in pancreatic acini. (1994) (7)
- Direct Identification and Characterization of β-Adrenergic Receptors and Functional Relationship of Adenylyl Cyclase (1978) (6)
- Receptor identification. (1990) (6)
- [35] Receptor identification (1990) (6)
- Mechanism by which dibutyryl cyclic guanosine monophosphate antagonizes the action of cholecystokinin. (1983) (6)
- Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors (2008) (6)
- Abnormal Erythrocyte Sodium Transport in Cystic Fibrosis (CF) (1970) (6)
- Effects of cations on ouabain binding by intact human erythrocytes (2005) (6)
- Characterization of receptors for gastrointestinal peptides. (1983) (5)
- Potential mechanisms of interaction among secretagogues. (1978) (5)
- Heartburn severity can predict pathologic oesophageal reflux in gastro‐oesophageal reflux disease patients treated with a proton‐pump inhibitor (2003) (5)
- Stimulation of secretion by secretagogues. (1990) (5)
- Cholecystokinin-induced residual stimulation of enzyme secretion from mouse pancreatic acini. (1987) (5)
- Plasma VIP in patients with watery diarrhea syndrome (1978) (5)
- Effect of beta-adrenergic catecholamines on sodium transport in turkey erythrocytes. (1973) (5)
- Effect of temperature on sodium transport in human erythrocytes in vitro. (1971) (5)
- Omeprazole: An Effective Drug for Zollinger-Ellison Syndrome (1986) (5)
- N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini. (1985) (5)
- Effect of Verapamil on the Cyclic AMP‐Mediated Pathway for Amylase Secretion in Rat Pancreatic Acini (1993) (4)
- GERD: Increased gastric acid secretion as a possible cause of GERD (2010) (4)
- The cytochemical section-bioassay of gastrin-like activity. (1980) (4)
- Characterization of a Persistent Inhibitory Action of L‐364,718 on Cholecystokinin‐Stimulated Enzyme Secretion in Pancreatic Acini (1994) (4)
- Preparation of dispersed pancreatic acinar cells and dispersed pancreatic acini. (1985) (4)
- In GERD patients taking a morning dose of omeprazole, bedtime low-dose ranitidine is equivalent to bedtime omeprazole for inhibition of nocturnal gastric acidity (2000) (4)
- Takayasu's arteritis: reversal of pulse deficit after early treatment with corticosteroids. (1984) (4)
- A two-site model for sodium transport in rabbit erythrocytes. (1971) (4)
- GERD Subjects with Increased Nocturnal Esophageal Acidity Have Increased Nocturnal Gastric Acidity: 4 (2005) (4)
- Zollinger-Ellison Syndrome in the Intensive Care Setting (1989) (4)
- Bombesin receptor antagonists. 2. Analogues based on substance P antagonists. (1991) (4)
- Biochemical basis of action of gastrointestinal hormones (1979) (3)
- Sodium outflux and ATPase activity in human and rabbit erythrocytes. (1971) (3)
- Zollinger-Ellison Syndrome: Advances in Diagnosis and Management (1991) (3)
- Comparison of Famotidine with Ranitidine and Cimetidine in the Treatment of Zollinger-Ellison Syndrome (1985) (3)
- The actions of tetraethylammonium on dispersed acini from guinea pig pancreas. (1983) (3)
- Carbachol-induced down-regulation of high-affinity receptors for vasoactive intestinal peptide. (1989) (3)
- Maximal or near-maximal inhibition of esophageal acidity by the 1st dose of rabeprazole in GERD (2000) (2)
- A newly recognized action of cholecystokinin on pancreatic acini-release of lactate dehydrogenase. (1993) (2)
- American gastroenterological association american association for the study of liver diseases gastroenterology research group New York city, May 18–20, 1981 (2007) (2)
- Exploring the physiologic role of human gastroesophageal reflux by analyzing time‐series data from 24‐h gastric and esophageal pH recordings (2014) (2)
- Endoscopy-negative GERD is a gastric ‘hypersecretory’ disorder (2000) (2)
- Insulin Action in Isolated Rat Thymocytes (2003) (2)
- Selective modification of the ability of cholecystokinin to cause residual stimulation of pancreatic enzyme secretion. (1982) (2)
- Determination of onset, duration of action and maximal effect of rabeprazole on gastric and esophageal acidity in GERD (2000) (2)
- The relationship between esophageal acidity and symptom frequency in symptomatic nonerosive gastroesophageal reflux disease (2022) (2)
- Letter: Gastric emptying. (1974) (2)
- How do I interpret a positive diagnostic test? (2007) (2)
- Tu1105 Attributable Risk - Interpreting Side Effects in Clinical Trials of Newer Treatments for Constipation at the Level of the Individual Patient (2016) (2)
- SYNTHESIS AND SOME PHARMACOLOGICAL PROPERTIES OF THE 23-PEPTIDE 15-LYSINE-SECRETIN-(5-27). SPECIAL ROLE OF THE RESIDUE IN POSITION 15 IN BIOLOGICAL ACTIVITY OF THE VASOACTIVE INTESTINAL POLYPEPTIDE (1979) (2)
- Timing and Outcomes of Endoscopy for esophageal Food Bolus Impaction (2022) (1)
- A two-site model for sodium transport in human erythrocytes. (1971) (1)
- Assay for the cholecystokinin receptor on pancreatic acini. (1985) (1)
- Cibacron blue-induced enhancement of agonist binding to cholecystokinin (CCK) receptors in solubilized pancreatic membranes. (1993) (1)
- The cellular basis of action of gastrointestinal peptides. (1984) (1)
- Diagnostic Performance of Esophageal pH Electrodes at Different Locations (2009) (1)
- The importance of calcium for the regulation of cyclic guanosine 3': 5'-monophosphate levels by pancreozymin, carbamoylcholine and ionophore A-23187 in isolated pancreatic acinar cells. (1975) (1)
- Prospective Assessment of the Safety and Efficacy of Long-term Omeprazole Therapy in Patients with Zollinger-Ellison Syndrome (1989) (1)
- COLORECTAL CANCER PREVENTION (2007) (1)
- Importance of the amino acid in position 15 of VIP and secretin in influencing their interactions with membrane receptors on pancreatic acinar cells. (1980) (1)
- Structure-Function Studies of Agonists and Antagonists for Gastrointestinal Peptide Receptors on Pancreatic Acinar Cells (1986) (1)
- Current Management of Zollinger-Ellison Syndrome (1986) (1)
- Carbachol-induced down-regulation of receptors for pancreatic secretagogues. (1990) (1)
- Receptors for Gut Peptides and Other Secretagogues on Pancreatic Acinar Cells (2011) (1)
- [Studies on the total synthesis of cholecystokinin-pancreozymin. Synthesis of the suitably protected fragment corresponding to the sequence 24--33 (author's transl)]. (1981) (1)
- Characterization of bombesin-receptors on dispersed guinea pig pancreatic acini (1987) (1)
- Cholecystokinin antagonists. (1986) (1)
- Direct neutralization of esophageal acid by antacid in meal-induced heartburn (2000) (1)
- Receptor modulation of calcium and cyclic AMP: differences in coupling to specific hormone-receptor complexes in cells responsive to several hormones. (1982) (1)
- Role of gastric acid in esophageal acid reflux (2001) (0)
- Subject Index, Vol. 46, Supplement 2, 1990 (1990) (0)
- In vivo gastric autotitration: a novel, simple method to measure meal-stimulated gastric acid secretion (2001) (0)
- Identification of a novel, beneficial action of proton pump inhibitors in GERD (2000) (0)
- Nocturnal Gastric Alkalinization in Healthy Human Subjects: 119 (2009) (0)
- Gastrointestinal abnormalities in systemic mastocytosis (1985) (0)
- Contents, Vol. 14, 1996 (1992) (0)
- M1856 Continuous Distal Esophageal Acidification Reduces Postprandial Gastric Acidity in Healthy Human Subjects (2009) (0)
- Specific Binding and Ability of Vasoactive Intestinal Octacosa-Peptide (VIP) to Activate Adenylate Cyclase in Isolated Pancreatic Acinar Cells from the Guinea Pig (1976) (0)
- SYNTHESIS AND SOME PHARMACOLOGICAL PROPERTIES OF Z-TYR(SO3H)-MET-GLY-TRP-MET-ASP(PHE-NH2)-OH, A 32-β-ASPARTYL ANALOG OF CHOLECYSTOKININ (PANCREOZYMIN)-27-33 (1982) (0)
- Clinicians and FDA Decisions (2008) (0)
- The columnar epithelial cell of the small intestine: digestion and transport. II. (1970) (0)
- Precise quantitation of nocturnal esophageal reflux in healthy subjects (2001) (0)
- Pancreatic acini as second messenger models in exocrine secretion. (1989) (0)
- by in vivo gastric autotitration Measurement of meal-stimulated gastric acid secretion (2015) (0)
- Relationship between esophageal acid exposure and heartburn severity in meal-lnduced heartburn (2000) (0)
- 1 – Role of Receptors in Expression of Gastrointestinal Hormone Function (1990) (0)
- Oesophageal pH has a power‐law distribution in control and gastro‐oesophageal reflux disease subjects. (2005) (0)
- Meal-induced heartburn: Quantification of esophageal acid exposure and its relationship to gastric acidity (2000) (0)
- Su1657 IN AN INDIVIDUAL WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID, THE PROBABILITY OF PRURITUS IS HIGHER THAN THAT OF A CLINICAL RESPONSE, BUT PRURITUS IS LESS LIKELY TO BE ATTRIBUTABLE TO THE DRUG. (2020) (0)
- Actions of cck jmv 180 on amylase secretion and release of lactic dehydrogenase ldh from pancreatic acini (1991) (0)
- Measurement of meal-stimulated gastric acid secretion and exophageal pH in ambulatory subjects who ingest typical meals (2001) (0)
- Characterization of the abnormality in esophageal acid exposure in gastroesophageal reflux disease (2002) (0)
- CLINICAL VIGNETTES (2020) (0)
- Inhibition of Gastrin-Responsiveness by Parietal Cell Antibodies (1979) (0)
- Su1070 Development of a Mobile Phone Application to Diagnose GERD (2012) (0)
- Heartburn severity can predict the presence of pathologic esophageal reflux in patients with GERD (2003) (0)
- Attributable Benefit -- Interpreting Results from Clinical Trials of Newer Treatments for Constipation at the Level of the Individual Patient (2017) (0)
- How do provocative meals cause heartburn? Integrated gastric acidity as the determinant of esophageal acid exposure (2000) (0)
- The Information Content of Esophageal pH Values in Vulcan Syndrome Differs from That in Normal and GERD Subjects: 20 (2006) (0)
- RECEPTOR ANTAGONISTS OF THE ACTIONS OF GASTROINTESTINAL PEPTIDES ON PANCREATIC ACINAR CELLS (1982) (0)
- Fasting gastric pH can predict the likelihood of pathologic esophageal reflux in gerd patients treated with a proton pump inhibitor (2003) (0)
- Measures of Effect Size Can Avoid Dependence of Odds Ratio and Relative Risk on the Control Response (2011) (0)
- Measures of Effect Size Provide Clinically Relevant Information Regarding the Beneficial Effects PN 400 on Naproxen-Induced Endoscopic Gastric Ulcers (2011) (0)
- Meal-stimulated gastric acid secretion in healthy subjects correlates with postprandial but not fasting gastric acidity (2001) (0)
- Functional Heartburn in a Non-Disease: 21 (2006) (0)
- Subject Index Vol. 14, 1996 (1996) (0)
- Esophageal acid sensitivity modulates response to acid reducing therapy in postprandial heartburn (2000) (0)
- Relationships Between Inhibition of Gastric and Esophageal Acidity in GERD Patients Being Treated with a Proton Pump Inhibitor: 31 (2008) (0)
- Missed opportunity in Zollinger-Ellison syndrome research. (2013) (0)
- 1018 A Questionable Investment for Our Patients: Challenging the Efficacy of New Therapies for Opioid-Induced and Chronic Idiopathic Constipation (2015) (0)
- Heartburn frequency can predict the presence of pathologic esophageal reflux in GERD patients without esophagitis during treatment with rabeprazole (2003) (0)
- News and notices (2005) (0)
- Increased postprandial gastric acidity is a major pathophysiologic abnormality in gastroesophageal reflux disease (2002) (0)
- Sa1075 Measures of Effect Size Provide Clinically Relevant Information Regarding the Beneficial Effects of Telaprevir in Hepatitis C (2012) (0)
- Title: IDENTIFYING DIFFERENT PHENOTYPES OF SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE USING ARTIFICIAL INTELLIGENCE Running Title: ARTIFICIAL INTELLIGENCE AND GASTROESOPHAGEAL REFLUX DISEASE (2023) (0)
- The Vulcan Syndrome – Asymptomatic Healthy Volunteers with Pathologic Esophageal Acid Exposure: 3 (2005) (0)
- Cholecystokinin receptor-mediated changes in cellular calcium transport (1983) (0)
- Subject Index, Vol. 32, Supplement 1, 1985 (1985) (0)
- Identification of two distinct pathophysiologic forms of GERD (2000) (0)
- CHOLECYSTOKININ (PANCREOZYMIN). 3. SYNTHESIS AND PROPERTIES OF AN ANALOG OF THE C-TERMINAL HEPTAPEPTIDE WITH SERINE SULFATE REPLACING TYROSINE SULFATE (1977) (0)
- A Method to Adjust pH Values Obtained with Different pH Catheters: 113 (2008) (0)
- THirteenth International Congress on Stomach Diseases (2007) (0)
- Nocturnal Gastric Acidity and Nocturnal Esophageal Acidity Are Lower with Immediate-Release Omeprazole Than with Lansoprazole or Esomeprazole in GERD Patients Treated with a Proton Pump Inhibitor: 3 (2007) (0)
- T1104 A Bayesian Method Using Esophageal Acid Exposure to Diagnose GERD (2010) (0)
- Response (1993) (0)
- Integrated acidity: a novel technique demonstrating synergy between low dose ranitidine and antacid for acid reduction and relief of meal-induced heartburn (2000) (0)
- Demonstration of interactions between different affinity states of the pancreatic cholecystokinin (CCK) receptor (1995) (0)
- CHOLECYSTOKININ (PANCREOZYMIN). 5. HORMONALLY ACTIVE DESAMINO DERIVATIVE OF TYR(SO3H)-MET-GLY-TRP-MET-ASP-PHE-NH2 (1980) (0)
- Integrated acidity and heartburn severity determine timing of self-medication in postprandial heartburn (2000) (0)
- Two different states of activation of cholecystokinin (CCK) receptors on pancreatic acinar cells (1980) (0)
- Su370 USING CLINICAL TRIAL RESULTS TO REMOVE THE UNCERTAINTY IN TREATING AN INDIVIDUAL PATIENT WITH CIRRHOSIS AND THROMBOCYTOPENIA (2021) (0)
- Role of cellular calcium in modulating the initial action of cholecystokinin on pancreatic acinar cells (1978) (0)
- Title: GASTRIC ACIDITY IN DIFFERENT PHENOTYPES OF SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE Running Title: GASTRIC ACIDITY IN GERD (2023) (0)
- Different mechanisms for carbachol induced down regulation of receptors for vasoactive intestinal peptide vip and cholecystokinin cck on pancreatic acini (1988) (0)
- S1932 A Bayesian Method for Analyzing Relationships Between Esophageal Reflux Episodes and Symptoms (2009) (0)
- The ability of operative endoscopic transillumina- Detection of Duodenal Gastrinomas by (1999) (0)
- The specific binding of radioiodinated vasoactive intestinal octacosapeptide (VIP) on isolated pancreatic acinar cells from the guinea pig. (1975) (0)
- SMALL INTESTINE/UNCLASSIFIED (2007) (0)
- Action of exogenous cyclic nucleotides on enzyme secretion from pancreatic acinar cells: Discovery of a competitive inhibitor of cholecystokinin (1978) (0)
- Reduced Nocturnal Gastric Alkalinization in Subjects with Gastroesophageal Reflux Disease: 123 (2009) (0)
- The Internet and the Journal. (1995) (0)
This paper list is powered by the following services: